Published May 2002 | Version v1
Journal article

Hepatocellular carcinoma

  • 1. The Aga Khan Univ., Hospital, Karachi (Pakistan). Dept. of Family Medicine

Description

Objective: To describe the etiology, clinico pathological features and outcome of hepatocellular carcinoma (HCC). Design: A retrospective study. Place and Duration of Study: The study was conducted at the Aga Khan University Hospital, Karachi, on patients admitted between January 1994 and December 1998. Subjects and Methods: A total of 201 consecutive patients diagnosed to have primary HCC on liver biopsy were the subjects of this study. Data included clinical and physical examination, routine hematological and bio-chemical investigations along with alpha-fetoprotein (alpha-FP or AFP) and imaging studies. Results: The mean age at the time of diagnosis was 56 years (24 to 85 year). There was a male preponderance (74%). The mean alpha FP was 17, 027 plus minus 68,853 ng/ml. The viral hepatitis profile was: HbsAg positive = 36% anti-HCV positive = 41%; both positive =7%: both negative = 16%. HBV-related HCC patients were found to be younger than HCV-related HCC patients (49.7 v/s 56.3 years: p =ns). However there was no significant difference in the survival rates of either group of patients. The median survival time was 16 weeks. Conclusion: HBV and HCV account for 84.% of HCC in Pakistan. Majority of the patients had advanced stage of HCC. The median survival was 16 weeks. (author)

Additional details

Publishing Information

Journal Title
JCPSP. Journal of the College of Physicians and Surgeons Pakistan
Journal Volume
12
Journal Issue
5
Journal Page Range
p. 264-267
ISSN
1022-386X

INIS

Country of Publication
Pakistan
Country of Input or Organization
Pakistan
INIS RN
34015821
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BIOPSY; DIAGNOSIS; HEPATITIS; HEPATOMAS; LIVER CIRRHOSIS; PATIENTS; THERAPY; VIRAL DISEASES
Descriptors DEC
CARCINOMAS; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM DISEASES; DISEASES; INFECTIOUS DISEASES; MEDICINE; NEOPLASMS